A Translational Study to Describe Clinical Characteristics, Biomarkers and to Identify Phenotypes and Endotypes associated with Differential Outcomes in Chinese Population

Study identifier:D2287R00186

ClinicalTrials.gov identifier:NCT06419413

EudraCT identifier:N/A

CTIS identifier:N/A

Recruiting

Official Title

A Transnational Study to Describe Asthma Patient Clinical Characteristics, Treatment Patterns, Biomarkers and to Identify Phenotypes and endotypes associated with Differential Outcomes that may Support Future Development of Personalized Treatment Strategies in Chinese Population

Medical condition

asthma

Phase

N/A

Healthy volunteers

Yes

Study drug

-

Sex

All

Estimated Enrollment

1000

Study type

Observational

Age

18 Years - 75 Years

Date

Study Start Date: 08 Jan 2024
Estimated Primary Completion Date: 08 Oct 2026
Estimated Study Completion Date: 08 Oct 2026

Study design

Allocation: N/A
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Dec 2024 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria